CIT - citron rho-interacting serine/threonine kinase Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 101094297
CIT Products (18)
| mRNA | Protein | Name |
|---|---|---|
| XM_019814616.2 | XP_019670175.1 | citron Rho-interacting kinase isoform X16 |
| XM_019814611.2 | XP_019670170.1 | citron Rho-interacting kinase isoform X4 |
| XM_019814610.2 | XP_019670169.1 | citron Rho-interacting kinase isoform X2 |
| XM_023241475.2 | XP_023097243.1 | citron Rho-interacting kinase isoform X13 |
| XM_006938519.4 | XP_006938581.1 | citron Rho-interacting kinase isoform X9 |
| XM_019814614.2 | XP_019670173.1 | citron Rho-interacting kinase isoform X15 |
| XM_045042124.1 | XP_044898059.1 | citron Rho-interacting kinase isoform X12 |
| XM_045042123.1 | XP_044898058.1 | citron Rho-interacting kinase isoform X11 |
| XM_045042122.1 | XP_044898057.1 | citron Rho-interacting kinase isoform X10 |
| XM_045042120.1 | XP_044898055.1 | citron Rho-interacting kinase isoform X7 |
| XM_045042117.1 | XP_044898052.1 | citron Rho-interacting kinase isoform X3 |
| XM_045042119.1 | XP_044898054.1 | citron Rho-interacting kinase isoform X6 |
| XM_045042118.1 | XP_044898053.1 | citron Rho-interacting kinase isoform X5 |
| XM_045042114.1 | XP_044898049.1 | citron Rho-interacting kinase isoform X1 |
| XM_045042121.1 | XP_044898056.1 | citron Rho-interacting kinase isoform X8 |
| XM_045042116.1 | XP_044898051.1 | citron Rho-interacting kinase isoform X1 |
| XM_045042115.1 | XP_044898050.1 | citron Rho-interacting kinase isoform X1 |
| XM_045042125.1 | XP_044898060.1 | citron Rho-interacting kinase isoform X14 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
citron Rho-interacting kinase |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99016A | Enfortumab vedotin-ejfv | Inhibitor | 99.69% | Unkown |
Clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-160441 | MC-Val-Cit-PAB-Ispinesib | Inhibitor | 99.85% | Phase 3 |
| HY-P99612 | Farletuzumab ecteribulin | 99.40% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(233)
Inhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99016B | Enfortumab vedotin-ejfv (solution) | Inhibitor | 99.78% | Unkown |
| HY-164154 | ADC Control Human IgG1-vcMMAF | Inhibitor | 97.28% | Unkown |